Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Tacrolimus (Systemic)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tacrolimus 1mg capsules
0802020T0AAABAB
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 379 |
|
Tacrolimus 500microgram capsules
0802020T0AAAFAF
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 186 |
|
Tacrolimus 5mg/5ml oral suspension
0802020T0AAALAL
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 81 |
|
Tacrolimus 2mg capsules
0802020T0AABGBG
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 70 |
|
Tacrolimus 1mg modified-release capsules
0802020T0AAANAN
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 32 |
|
Tacrolimus 2.5mg/5ml oral liquid
0802020T0AAAGAG
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 32 |
|
Tacrolimus 1mg gran for susp sachets sugar free
0802020T0AAAWAW
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 23 |
|
Tacrolimus 5mg capsules
0802020T0AAAAAA
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 23 |
|
Tacrolimus 750microgram capsules
0802020T0AABFBF
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 18 |
|
Tacrolimus 5mg modified-release capsules
0802020T0AAAPAP
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 17 |
|
Tacrolimus 200microgram gran for susp sachets sugar free
0802020T0AAAVAV
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 12 |
|
Tacrolimus 3mg modified-release capsules
0802020T0AAATAT
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 9 |
|
Tacrolimus 500microgram modified-release capsules
0802020T0AAAMAM
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 9 |
|
Tacrolimus 1mg modified-release tablets
0802020T0AABCBC
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 4 |
|
Tacrolimus 2mg modified-release capsules
0802020T0AABJBJ
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 2 |
|
Tacrolimus 4mg modified-release tablets
0802020T0AABEBE
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 1 |
|
Tacrolimus 0.0001% mouthwash
0802020T0AAAXAX
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 25mg/5ml oral liquid
0802020T0AAASAS
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 2mg suppositories
0802020T0AABIBI
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 2mg/5ml oral suspension
0802020T0AAAKAK
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 500micrograms/5ml oral suspension
0802020T0AAARAR
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 5mg/1ml solution for infusion ampoules
0802020T0AAACAC
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 750microgram modified-release tablets
0802020T0AABDBD
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 800micrograms/5ml oral solution
0802020T0AABABA
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 900micrograms/5ml oral suspension
0802020T0AABBBB
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.